Morgan Stanley Maintains Overweight on Boston Scientific, Raises Price Target to $61
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood has maintained an Overweight rating on Boston Scientific (NYSE:BSX) and increased the price target from $58 to $61.
December 04, 2023 | 1:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley analyst reaffirms an Overweight rating on Boston Scientific and raises the price target to $61.
The increase in price target by a reputable analyst like Morgan Stanley suggests a positive outlook on the company's future performance, which can lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100